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TransplantationTo investigate the effect of resident cardiac stem cells (RCSC) on myocardial remodeling, c-kit+ RCSC were
isolated from hearts of C57Bl/6-Tg (ACTb-EGFP)1Osb/J mice expressing green ﬂuorescent protein and expanded
in vitro. C57/Bl6N wildtype mice were subjected to transverse aortic constriction (TAC, 360 μm) or
sham-operation. 5 × 105 c-kit+ RCSC or c-kit− cardiac cells or cell buffer were infused intravenously 24 h post-
surgery (n= 11–24 per group). Hypoxia-inducible factor-1α-mRNA in left ventricles of TACmice was enhanced
24h after transplantation. 35 days post-TAC, the density of c-kit+ RCSC in themyocardiumwas increased by two-
fold. Infusion of c-kit+ resident cardiac stem cells post-TACmarkedly reducedmyocardialﬁbrosis and the expres-
sion of collagen Iα2 and connective tissue growth factor. Infusion of c-kit− cardiac cells did not ameliorate cardiac
ﬁbrosis. In parallel, expression of pro-angiogenic mediators (FGFb, IL-4, IL-6, TGFß, leptin) and the density of
CD31+ and CD31+ GFP+ endothelial cells were increased. Transplantation reduced brain- and atrial natriuretic
peptides and the cardiomyocyte cross-sectional area. Infusion of c-kit+ resident cardiac stem reduced the rate
of apoptosis and oxidative stress in cardiomyocytes and in non-cardiomyocyte cells.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Hypertrophy, cardiac ﬁbrosis and deterioration of myocardial
capillarization are major components of cardiac remodeling e.g. caused
by sustained pressure overload that can ultimately lead to heart failure
(Burchﬁeld et al. 2013; Segura et al. 2014). There is evidence that
cardiomyocytes can repopulate in the human heart, but this process
appears to be very slow and only a low number of cardiomyocytes
appears to be exchanged over the course of a human life span
(Bergmann and Jovinge 2014; Buja and Vela 2008; Senyo et al. 2013).
Moreover, adverse tissue remodeling, particularly cardiac ﬁbrosis, in
pathological conditions disturbs renewal of cardiomyocytes and other
cardiac cells (Bergmann and Jovinge 2014; Buja and Vela 2008;
Kazakov et al. 2013; Kazakov et al. 2012; Müller et al. 2009; Müller
et al. 2008; Senyo et al. 2013). Recent investigations suggest participa-
tion of bone-marrow derived stem cells and resident cardiac stem
cells (RCSC) during normal and pathological remodeling of the adultIII, Kardiologie, Angiologie und
, Kirrberger Straße, Gebäude 40,
d.de (A. Kazakov).
. This is an open access article underheart (Beltrami et al. 2003; Bergmann and Jovinge 2014; Ellison et al.
2013; Hierlihy et al. 2002; Kazakov et al. 2013; Kazakov et al. 2012;
Müller et al. 2009; Müller et al. 2008; Senyo et al. 2013; van Berlo
et al. 2014). The adult endogenous c-kit+ CD45− tryptase− CD31−
CD34− cardiac stem cells (c-kit+ RCSC) participate in myocardial adap-
tation to physiological and pathological stimuli (Beltrami et al. 2003;
Ellison et al. 2013; Hierlihy et al. 2002; van Berlo et al. 2014). Further-
more, intramyocardial and intracoronary transplantation of c-kit+
RCSC has been observed to improve cardiac regeneration (Beltrami
et al. 2003; Ellison et al. 2013; Li et al. 2011). However, their role inmal-
adaptive cardiac remodeling caused by sustained pressure overload is
not completely understood (Rupp et al. 2012). Pressure overload, e.g.
induced by aortic stenosis or arterial hypertension is a common cause
of myocardial remodeling. Therefore, we investigated the inﬂuence of
intravenous transplantation of c-kit+ resident cardiac stem cells on
cardiac remodeling induced by transverse aortic constriction.
2. Methods
2.1. Animals, transverse aortic constriction
The study was approved by the animal Ethics Committee of the
Universität des Saarlandes and conforms with the Guide for the Carethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Assessment and Accreditation of Laboratory Animal Care (NRC 2011).
Ten-week-old male C57/Bl6 (Charles River Laboratories, Sulzfeld,
Germany) mice were housed under standard conditions. For surgery
and left ventricle (LV)-pressuremeasurements animalswere intraperito-
neally anesthetizedwith 100mg/kg bodyweight ketaminehydrochloride
(Ketanest®, Pﬁzer, Berlin, Germany) and 10 mg/kg body weight
xylazinehydrochloride (Rompun® 2%, Bayer, Leverkusen, Germany).
Anesthetic monitoring was performed by testing of rear foot reﬂexes
before and during procedures, observation of respiratory pattern, mu-
cousmembrane color, and responsiveness tomanipulations throughout
the procedures. After orotracheal intubation using a 20 G catheter, the
tube was connected to a volume cycled rodent ventilator (Harvard Ap-
paratus, USA) on supplemental oxygen with a tidal volume of 0.2 mL
and respiratory rate of 110 min−1. The chest cavity was entered in the
second intercostal space at the left upper sternal border through a
small incision and aortic constriction was performed by tying a 7–0
nylon suture ligature against a 27 G needle to yield a narrowing
360 μm in diameter and a transverse aortic constriction (TAC) of
65–70%. Control mice underwent a sham operation. Intravenous trans-
plantation of c-kit+ RCSCwas performed 24h post-surgery as described
below. After 5weeks, LV-pressuremeasurements were performedwith
1.4 Fr pressure-transducing catheter (Mikro Tip Catheter, Millar instru-
ments, USA). Mice were sacriﬁced 3 h, 24 h and 5 weeks after stem cell
transplantation by i.p. injection of ketamine (1 g/kg body weight) and
xylazine (100 mg/kg) and hearts were rapidly excised. Hearts and
other internal organs were partly snap-frozen in liquid nitrogen and
stored at −80 °C and partly embedded in parafﬁn after ﬁxation in
PBS-buffered formalin (4%).
2.2. Cardiac c-kit+ cells: isolation, culture and intravenous transplantation
Ten-week old C57Bl/6-Tg(ACTbEGFP)1Osb mice (Jackson laborato-
ry; expressing green ﬂuorescent protein (GFP) ubiquitously) were
sacriﬁced by i.p. injection of ketamine (1 g/kg body weight) and
xylazine (10 mg/kg). Cardiac cells isolated by heart perfusion with
0.1% collagenase (Worthington, USA) for 23 min and mincing in
Ham's F-12 medium (Sigma-Aldrich, Germany) were centrifuged,
supplemented with the fresh medium, sorted with mouse anti-c-kit
antibody conjugated with magnetic beads (Miltenyi Biotec, Germany)
for 15 min and separated by magnet-activated cell sorting into c-kit+
and c-kit− fractions (Fig. 1). c-kit+ RCSC and c-kit− cardiac cells
(c-kit−CC) were expanded in cell culture until the second passage and
partly immunostained for stem cell markers c-kit (Santa Cruz Biotech-
nology, USA) Oct3/4 and Kruppel-like factor 4 (Klf4) (abcam, UK)
(Fig. 1). Cells at 85% conﬂuence in cell culture dishes were harvested
by trypsinization (Invitrogen, Germany) and passed through a 40 μm
cell strainer (BD Bioscience, USA). 5×105 c-kit+ RCSC resuspended in
stem cell buffer (provided in detail in the Supplementary material on-
line) were infused in the tail vein of SHAM + cells (c-kit+) and
TAC + cells (c-kit+) mice 24 h post-surgery (n = 15–24 per group).
Controlmice received an injection of the stem cell buffer (SHAM+buff-
er, TAC + buffer n = 11–16 per group). To control the speciﬁcity of the
effects observed after c-kit+ RCSC transplantation, 5×105 c-kit− cardiac
cells were infused in the tail vein of SHAM + c-kit− (n = 3) and
TAC+ c-kit− (n= 4)mice. For this purpose animals were anesthetized
by inhalation of 2% isoﬂurane and the adequacy of anesthesia was eval-
uated as described above. To prevent embolization, all mice prior to
stem cells or vehicle injection were intravenously injected with 200 μl
(20 USP units) heparin (B.Braun Melsungen AG, Germany) and 50 μl
of 0.5 mg/ml sodium nitroprusside (1 mg/kg body weight) (Schwarz
Pharma, Germany) (Boomsma et al. 2007). For transplantation of
Tie-2-GFP c-kit+ RCSC, Tie-2-GFP mice (FVB/NTgN[TIE2GFP]287Sato;
Jackson Laboratory)were used as donors of c-kit+ RCSC, and unoperated
wild-type FVB/NJ mice (Charles River, Germany), n = 5, were used as
recipients (Müller et al. 2009). To investigate differentiation capability,c-kit+ RCSC isolated from 8mice were cultivated until the third passage
in stem cell mediumor for 3 days and 5weeks in differentiationmedium
(Minimum essential medium eagle, alpha modiﬁcation Sigma-Aldrich,
Germany) supplemented with 10% calf serum (PAA, Austria) and dexa-
methasone (Sigma-Aldrich, Germany) and immunostained for marker
of stem cells stem cell antigen-1(Sca-1) (Cedarlane, Canada), CD34
(DAKO, Germany), mast cell tryptase (DAKO, Germany), leucocytes
CD45 (abcam, UK), endothelial cell podocalyxin (R&D Systems, USA),
vonWillebrand factor (abcam,UK), CD31 (abcam,UK),ﬁbroblastmarker
discoidin domain-containing receptor 2 (DDR2) (Santa Cruz Biotechnol-
ogy, USA), smooth muscle cell marker α-smooth muscle actin (Sigma-
Aldrich, Germany), cardiomyocyte marker cardiac troponin T–C (Santa
Cruz Biotechnology, USA) and receptor of SDF-1 CXCR4 (abcam, UK).
To estimate the extent of c-kit+ RCSC differentiation each immunostain-
ing was performed on three cell culture dishes per mouse and the
number of cells immunostained for analyzing marker per 300 cells
were counted in each cell culture dish.
2.3. Immunoﬂuorescence analysis
To detect c-kit+ RCSC, cardiomyocytes, endothelial cells, smooth
muscle cells, ﬁbroblasts, hepatocytes, nestin+ cells, GFP+ cells, Ki67+
cycling cells and level of oxidative stress immunostainings on 3 μmpar-
afﬁn sections of the LVwere performed using heat-mediated antigen re-
trieval with citraconic anhydride solution followed by overnight
incubation at 4 °C with the primary antibody and incubation with the
appropriate secondary antibody at 37 °C for 1 h. The detailed methods
are described in the Supplementary material online.
2.4. Apoptosis
Apoptosis detection was performed on 3 μm thin sections of
formalin-ﬁxed heart sections with the ApopTag Peroxidase In Situ
Oligo Ligation Kit (Millipore, Germany). To evaluate apoptosis rate in
cardiomyocytes and non-cardiomyocytes, immunostaining for cardio-
myocyte marker α-sarcomeric actin (Sigma-Aldrich, Germany) was
performed. The analysis protocol is described in more detail in the
Supplementary material online.
2.5. Tissue morphometry
The procedures used for morphometric analyses are provided in
detail in the Supplementary material online.
2.6. Expression analysis
Gene expression was measured by the real-time quantitative reverse
transcriptase-polymerase chain reaction (RT-PCR) using the TaqMan sys-
tem (AB Step One Plus, Applied Biosystems, Germany). Brieﬂy, RNA from
the LV myocardium was extracted using the peqGOLD RNAPure (Peqlab
Biotechnologie, Germany). Oligo (dT) primed cDNA synthesis was per-
formedwith High capacity cDNA reverse transcription kit (Life Technolo-
gies, Germany). Expression of collagen Iα2 (Mm01165187_m1),
brain natriuretic peptide (BNP) (Mm01255770_g1), atrial natriuretic
peptide (ANP) (Mm01255747_g1), connective tissue growth factor
(CTGF), (Mm01192931_g1), hypoxia-inducible factor-1α (Hif1α)
(Mm00468869_m1), Oct3/4 (Mm03053917_g1), hypoxanthine-
guanine phosphoribosyltransferase (HGPRT) (Mm 01545399_m1) and
18S rRNA was analyzed with TaqMan gene expression assays-on-
demand purchased from Life Technologies. For quantiﬁcation, mRNA
amount of the respective gene was normalized to the amount of 18S
rRNA and HGPRT using the 2−ΔΔCT method. To assess activators and
inhibitors of angiogenesis in the LVmyocardium, tissue protein extracts
were analyzed using the Mouse Angiogenesis Antibody Array Kit
(Affymetrix, UK). The BNP level in the peripheral blood was analyzed
by enzyme immunoassay (RayBiotech, USA).
Fig. 1. Isolation and transplantation of GFP+ c-kit+ cells. Cardiac cells from C57Bl/6-Tg(ACTbEGFP)1Osbmicewere isolated by heart perfusionwith collagenase, sortedwithmouse anti-c-
kit antibody conjugated with magnetic beads and separated by magnet-activated cell sorting into c-kit+ and c-kit− fractions. c-kit+ RCSC were expanded in the cell culture and
immunostained for stem cell markers c-kit (red) and Oct3/4 (red), Klf4 (red), and GFP (green). Nuclei are stained blue by DAPI. Each immunostaining was performed on 3 cell culture
dishes permouse (n=8) andnumber of cells immunostained for stemcellmarker per 300 cellswere counted in each cell culture dish. 5 × 105 c-kit+ RCSC resuspended in stemcell buffer
were infused in the tail vein of ten-week-old male C57/Bl6 SHAM+ cells (n= 15) and TAC+ cells (n= 24) mice 24 h post-surgery. Control mice SHAM+ buffer (n = 11) and TAC+
buffer (n = 16) received an injection of the stem cell buffer. To exclude unspeciﬁc effects of c-kit+ RCSC transplantation, 5 × 105 c-kit− cardiac cells were infused in the tail vein of
SHAM+ c-kit− (n = 3) and TAC + c-kit− (n = 4) mice. Mice were sacriﬁced after 5 weeks and organs were harvested. Bars = 10 μm.
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Results are presented as mean± standard error of the mean (SEM).
Mann–Whitney tests were used for the comparison of two groups. For
experiments with more than two groups, one-way ANOVA with
Fisher-LSD post-hoc tests were used. Correlations were assessed with
Spearman analyses. Values of p b 0.05 were considered signiﬁcant.
SPSS version 18.0 (SPSS Inc., Chicago, Illinois) was used for statistical
calculations.
3. Results
3.1. C-kit+ RCSC differentiate into main cardiac lineages and migrate to the
myocardium
Immunostaining revealed that all isolated and expanded in cell
culture resident cardiac stem cells were positive for c-kit and 80%
expressed Oct3/4 and Klf4 in the nucleus (Fig. 1, Suppl. Fig. 3).
C-kit−cardiac cells were negative for Oct3/4 and Klf4. Transplanted
cells were c-kit+ Sca-1− CD45− CD31− CD34− tryptase− (Fig. 2).
Stem cells cultivated in Ham's F-12 stem cell medium until the third
passage spontaneously differentiated and expressed markers of main
cardiac linages, the endothelial markers podocalyxin, CD31 and von
Willebrand factor, the cardiomyocyte marker troponin T–C, the smooth
muscle cell marker α-smooth muscle actin, the ﬁbroblast marker DDR2
and SDF-1 receptor CXCR4 (Fig. 2A–E). The most pronounced increase
was observed for the endothelial cell markers podocalyxin and von
Willebrand factor (20 to 30-fold, Fig. 2A–B).
Longer cultivation for 5 weeks in differentiation medium induced
differentiation of c-kit+ GFP+ RCSC mainly towards a smooth muscle
phenotype. 28.2 ± 5.2% of the cells expressed α-smooth muscle actin,
9.7 ± 2% expressed cardiac troponin T–C, 16.7 ± 5% and 12.1 ± 3%
expressed podocalyxin and von Willebrand factor respectively and
15.5 ± 2% expressed DDR2 (Fig. 2A–E).
c-kit+ GFP+ RCSC injected intravenously migrated to the heart and
other internal organs where they were detectable as early as 3 h after
injection (Fig. 3A, D, E, J). ThemRNA-expression level of Oct3/4 was sig-
niﬁcantly increased in the pressure-overloaded myocardium 24 h after
c-kit+ RCSC-transplantation (Fig. 3F). Pressure overload for 3 h, 24 h
and 5 weeks led to a two-fold increase of GFP+ injected cells per mm2
in the LV myocardium (Fig. 3A–C). GFP+ cardiomyocytes were identi-
ﬁed in 3 of 24 (12%) TAC + cell mice (Fig. 3K). GFP+ cells were also
found in the lungs, spleen, kidneys and liver of RCSC-transplanted
mice 5 weeks after transplantation (Fig. 3L). In the liver of four
(12.8%) RCSC-transplanted animals, GFP+ cells expressing the hepato-
cyte marker cytokeratin 8 were detected (Fig. 3M). About 25% of
injected GFP+ cells expressed c-kit or α-smooth muscle actin 5 weeks
after transplantation (Fig. 3G, H, N, O). Injection of c-kit+ GFP+ RCSC in-
creased the number of nestin-positive GFP-negative cardiomyocytes
during pressure overload for 5 weeks (Fig. 3I, P).
3.2. Intravenous transplantation of c-kit+ RCSC improves parameters of LV
hemodynamics and reduces cardiomyocyte cross-sectional area
Transverse aortic constriction increased LVSP, LVEDP, dP/dtmax, the
ratio of wet lung weight to tibia length, and decreased dP/dtmin
(Table 1). As expected, TAC induced both myocardial (increased ratio
of heart weight to tibia length) and cardiomyocyte hypertrophy
(increased cardiomyocyte cross-sectional area). Transplantation of
c-kit+ RCSC improved LV systolic and diastolic function (elevated
LVdP/dtmax and diminished LVdP/dtmin), reduced the cardiomyocyte
cross-sectional area and increased cardiomyocyte density (Table 1).
Transplantation of c-kit− cardiac cells did not improve parameters of
LV hemodynamics and cardiomyocyte hypertrophy during TAC
(Table 1).3.3. Increase of endothelial cell number and Hif1α-expression in the
pressure-overloaded myocardium after c-kit+ RCSC transplantation
Transplantation of c-kit+ RCSC increased the number of CD31+
endothelial cells per mm2 but not the ratio of CD31+ endothelial cells
to α-sarcomeric actin-positive cardiomyocytes in TAC mice (Fig. 4A, B,
E). Transplanted cells differentiated into CD31+ cells and pressure over-
load signiﬁcantly increased their percentage (Fig. 4C, D, F). To assess
whether transplanted c-kit+ RCSC were transdifferentiating into endo-
thelial cells in our model and to exclude the possibility that the ﬁndings
were due to non-endothelial cells lying in the vicinity of true endothelial
cells, transplantation studies of c-kit+ RCSC from Tie-2-GFP FVB/Nmice
into their wild-type FVB/N mice were performed. After c-kit+ RCSC
transplantation from Tie-2-GFP mice, all animals showed GFP-positive
cells in the heart (Fig. 4G). GFP expression in these mice is under the
control of the endothelial promoter Tie-2. In the c-kit+ RCSC recipients,
GFP-positive cells therefore represent endothelial cells from injected
c-kit+ RCSC.
Real-time PCR of myocardial tissue revealed increased Hif1αmRNA
expression 24 h after c-kit+ RCSC transplantation in pressure-
overloaded myocardium (SHAM + buffer 100 ± 18%, SHAM + cells
104 ± 20%, TAC + cells 209 ± 41% vs. TAC + buffer 108 ± 10%, p =
0.01) (Fig. 4H). Five weeks after the transplantation, Hif1αmRNA was
down-regulated in all groups with the exception of SHAM + buffer
(SHAM + buffer 100 ± 30%, SHAM + cells 58 ± 30%, TAC + cells
50 ± 15% vs. TAC + buffer 50 ± 18%, n.s.) (Fig. 4H).
3.4. Transplantation of c-kit+ RCSC shifts the balance between activators
and inhibitors of angiogenesis towards activators
Total protein concentration of all pro-angiogenic mediators in the
pressure-overloaded LV myocardium was not signiﬁcantly changed
24 h after c-kit+ RCSC transplantation (Fig. 4I). Speciﬁcally, the summa-
rized expression of epidermal growth factor (EGF), acidic ﬁbroblast
growth factor (FGFa), basic ﬁbroblast growth factor (FGFb),
granulocyte-colony stimulating factor (G-CSF), interleukin-1alpha (IL-
1α), interleukin-1 beta (IL-1β), interleukin-4 (IL-4), interleukin-6 (IL-
6), leptin, transforming growth factor alpha (TGFα), and transforming
growth factor beta (TGFβ), tumor necrosis factor alpha (TNFα), vascular
endothelial growth factor (VEGF) remained unchanged (Fig. 4I). Five
weeks post-transplantation, protein expression of all pro-angiogenic
mediators in the pressure-overloaded LV was signiﬁcantly increased,
p = 0.0004 (Fig. 4I). Speciﬁcally, the expression of FGFb, IL-4, IL-6,
leptin, TGFβwas signiﬁcantly increased by two- to four-fold (Fig. 4K).
In contrast, expression of all anti-angiogenic factors was markedly
reduced 24 h post-transplantation, p = 0.04 (Fig. 4I). Speciﬁcally, the
expression of interferon gamma (IFNγ) and IFNγ-inducible protein 10
(IP-10) was reduced by 30–60% (Fig. 4J). Although ﬁve weeks after
stem cell transplantation, an over-all increased expression of all anti-
angiogenic factors IFNγ; interleukin-12 (IL-12), IP-10, tissue inhibitor
of metalloproteinases 1 and 2 (TIMP-1,TIMP-2) was observed, p =
0.04, protein concentration of pro-angiogenic mediators in the
pressure-overloaded LV was higher, p = 0.04 (Fig. 4I). In summary,
the intravenous transplantation of c-kit+ RCSC shifted the balance
between activators and inhibitors of angiogenesis towards activators
in the pressure-overloaded myocardium.
3.5. Intravenous transplantation of c-kit+ RCSC reduces myocardial level of
oxidative stress and cardiac ﬁbrosis in TAC
Intravenous infusion of c-kit+ RCSC diminished oxidative stress
induced by pressure-overload both in cardiomyocytes and in non-
cardiomyocytes evaluated by immunostaining for 8-hydroxy-
guanosine (Fig. 5A, B, K, Suppl. Fig. 4) and reduced myocardial collagen
Iα2 and CTGF mRNA expression (Fig. 5C, D). Spearman correlation
Fig. 2. Cultivated c-kit+ resident cardiac stem cells acquire an endothelial phenotype in stem cell medium and a smooth myocyte phenotype in differentiation medium. Cultiva-
tion of c-kit+ GFP+ RCSC until the third passage in Ham's F-12 stem cell medium and for 5 weeks in differentiation medium increases the percentage of podocalyxin+ (A) (red)
and von Willebrand factor+ endothelial-like cells (B), (red). Cultivation in differentiation medium also signiﬁcantly increases the percentage of smooth α-actin+ smooth
muscle-like cells (C) (red), cardiac troponin T–C+ cardiomyocyte-like cells (D) (red) and DDR2+ ﬁbroblast-like cells (E) (red). Transplanted cells do not express stem cell
antigen 1, leucocyte marker CD45, endothelial cell marker CD31, CD34 and tryptase (red). All cells exhibit GFP ﬂuorescence (green) and CXCR4 expression (red). Each
immunostaining was performed on 3 cell culture dishes per mouse (n = 8) and number of cells immunostained for differentiation marker per 300 cells were counted in each
cell culture dish. Nuclei are stained blue by DAPI. Bars =10 μm.
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Fig. 3. Injected c-kit+ resident cardiac stem cells migrate to the heart and other internal organs. Injected c-kit+ GFP+ RCSC migrate to the heart and other internal organs. Pressure overload
signiﬁcantly increases the number of GFP+ cells per mm2 3 h (A), 24 h (B) and 5 weeks (C) after stem cell transplantation, n= 4–5 per group. Transplanted c-kit+ GFP+ RCSC were detected
in the lung (D) and liver (E) of SHAM and TACmice. C-kit+ GFP+RCSC transplantation increasesmRNA-expression level of Oct3/4 in the LVmyocardium of TAC+ cell mice 24 h later, n= 4–5
per group (F). About 25%of injectedGFP+cells express c-kit (G) orα-smoothmuscle actin (H) 5weeks after transplantation, n=5per group. Stemcell transplantation increases thepercentage
of GFP-negative nestin-positive cardiomyocytes in TAC+ cell mice (I), n= 11–24 per group. GFP+ cells in LV sections from a TAC+ cell mouse 3 h after stem cell transplantation: GFP+ cells
between cardiomyocytes-overlay (J) and aGFP+ cardiomyocyte-overlay in a TAC+ cellmouse 5weeks post-TAC (K):α-sarcomeric actin (red) andGFP (green). GFP+ (green) cells in the lung,
spleen, kidney and liver sections 5 weeks post-injection are marked by arrowheads (L). A GFP+ hepatocyte-overlay 5 weeks after stem cell injection (M): cytokeratin 8 (red) and GFP (green).
C-kit+GFP+ cell-overlay in a TAC+cellmouse 5weeks post-TAC (N): c-kit (red) andGFP (green). AGFP+ smoothmuscle cell overlay in a TAC+cellmouse 5weeks post-TAC (O):α-smooth
muscle actin (red) and GFP (green). A small nestin-positive GFP-negative cardiomyocyte-overlay in a TAC + cell mouse 5 weeks post-TAC (P): α-sarcomeric actin (red) and nestin (green).
Nuclei are stained blue by DAPI. Bars = 10 μm.
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Table 1
Effects of transverse aortic constriction (TAC) and transplantation on parameters of myocardial hypertrophy.
SHAM + buffer SHAM + c-kit− SHAM+ cells TAC + c-kit− TAC + buffer TAC + cells
Animal number 11 3 15 4 16 24
Body weight (g) 25 ± 0.4 24 ± 1.4 26 ± 0.4 24.7 ± 0.6 24.9 ± 0.8 25.2 ± 0.4
Heart rate (b.p.m.) 164 ± 7 186 ± 15 173 ± 6 199 ± 4 167 ± 8 175 ± 15
LVSP (mm Hg) 75 ± 3 79 ± 6 79 ± 3 164 ± 4⁎,† 117 ± 6⁎ 127 ± 5⁎,†,‡
LVdP/dt max (mm Hg/s) 2565 ± 179 3086 ± 319 2582 ± 145 4486 ± 90⁎ 3106 ± 137⁎ 3534 ± 140⁎,†,‡
LVdP/dtmin (mm Hg/s) −2233 ± 197 −2724 ± 329 −2286 ± 141 −5311 ± 161⁎ −3180 ± 168⁎ −3708 ± 206⁎,†,‡
LVEDP (mm Hg) 17 ± 2 12 ± 0.5 19 ± 2.5 29 ± 2⁎ 27.5 ± 1.3⁎ 30.7 ± 2.6⁎
Lung ﬂuid weight/TL (mg/mm) 10.3 ± 0.6 9.3 ± 0.4 9.8 ± 0.5 18.7 ± 0.3 16.4 ± 1.8⁎ 18.4 ± 1.7⁎
Heart weight/TL (mg/mm) 7.8 ± 0.4 7 ± 0.4 8.2 ± 0.3 11.8 ± 0.3⁎ 12.7 ± 0.9⁎ 13.7 ± 0.8⁎
CCSA (μm2) 248 ± 22 220 ± 20 248 ± 15 435 ± 26⁎,† 358 ± 15⁎ 312 ± 14⁎,†,‡
Cardiomyocytes (/mm2) 5525 ± 469 6696 ± 514 5430 ± 259 3709 ± 219⁎ 3874 ± 185⁎ 4455 ± 227⁎,†,‡
CCSA, cardiomyocyte cross-sectional area; LV, left ventricle; LVEDP, left ventricular end-diastolic pressure; LVSP, left ventricular systolic pressure; and TL, tibia length.
Data are presented as means ± SEM. One-way ANOVA with a Fisher-LSD post-hoc test.
⁎ p b 0.05 vs. corresponding control group.
† p b 0.05 vs. TAC + buffer.
‡ p b 0.05 vs. TAC + c-kit−.
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expression level of CTGF and collagen Iα2 (r = 0.7, p = 0.6 × 10−6).
Cardiac ﬁbrosis was quantiﬁed morphometrically as fractional area
of collagen content in % of myocardial content using picrosirius red
staining. TAC led to a profound replacement ﬁbrosis, which was signiﬁ-
cantly diminished by c-kit+ RCSC transplantation (Fig. 5G, L). Further-
more, transplanted stem cells reduced the number of cardiac
ﬁbroblast identiﬁed by immunostaining for intracellular ﬁbronectin
and DDR2 in the pressure-overloaded LV (Fig. 5I, J, M, N). Transplanta-
tion of c-kit negative cardiac cells, similar to the injection of stem cell
buffer, did not ameliorate cardiac ﬁbrosis in pressure overload. Neither
fractional area of collagen content, nor collagen Iα2 mRNA expression
was reduced after c-kit− CC transplantation (Fig. 5E, F, H, L).
3.6. Amelioration of myocardial cell turnover and mRNA-expression of BNP
and ANP in pressure-overloaded LV myocardium after c-kit+ RCSC
transplantation
TAC enhanced apoptosis of cardiomyocytes but not of non-
cardiomyocytes. The extent of apoptosis caused by pressure over-
load was markedly decreased by c-kit+ RCSC transplantation in
cardiomyocytes and in non-cardiomyocytes (Fig. 6A–D).
Transplantation of c-kit+ RCSC increased the percentage of cycling
Ki67+ cardiomyocytes in the SHAM+ cells group and the percentage
of cycling Ki67+ non-cardiomyocytes in both experimental groups
(Fig. 6E, F, H, I, J, Suppl. Fig. 5). GFP+ Ki67+ cells were detected in the
LV myocardium of transplanted animals (Fig. 6K, Suppl. Fig. 5). More-
over, transplantation of c-kit+ RCSC signiﬁcantly increased the percent-
age of nestin+ Ki67+ non-cardiomyocytes in pressure-overloaded LV
(Fig. 6G, L, Suppl. Fig. 5).
Myocardial content of natriuretic peptides is a marker of cardiac re-
modeling andprogression to heart failure. TAC increased themyocardial
content of BNP and ANP by ﬁve- to twenty-fold. The up-regulation of
BNP and ANPwas markedly diminished by c-kit+ RCSC transplantation
(Fig. 6M, N). Transplantation of c-kit+ RCSC also reduced the concentra-
tion of BNP in the serum of TAC mice (Fig. 6O).
4. Discussion
The main ﬁnding of the study is the amelioration of pressure-
overload induced left ventricular remodeling by intravenous infusion
of adult c-kit+ resident cardiac stem cells. We isolated adult c-kit+
RCSC that expressed c-kit in the cell membrane and Oct3/4 in the nucle-
us (Lennartsson and Ronnstrand 2012; Liedtke et al. 2008). Speciﬁc
transcription factors (MEF-2C, GATA-4, GATA-6, Nkx2.5, Ets1) regulate
the differentiation of c-kit+ RCSC into various cardiac cells both
in vitro and in vivo (Beltrami et al. 2003; Ellison et al. 2013; Li et al.2011; van Berlo et al. 2014). In agreement with these ﬁndings, the ex-
panded c-kit+ RCSC differentiated into the main three cardiac linages:
cardiomyocyte, endothelial and smooth muscle cells. C-kit+ RCSC culti-
vated in stem cell medium spontaneously differentiated primarily into
endothelial cells explaining their high angiogenic activity (Russell and
Brown 2014; Sandstedt et al. 2010). Transplantation of c-kit+ RCSC
markedly reduced ﬁbrosis, ﬁbroblast density, expression of CTGF and
collagen Iα2, cardiomyocyte hypertrophy and increased cardiomyocyte
density in the left ventricular myocardium. These ameliorative effects
are at least in part explained by the observed reduction of apoptotic
cell death and oxidative stress and the enhanced proliferation of cardiac
cells.
Transplantation of c-kit+ RCSC shifted the balance between pro- and
anti-angiogenic proteins in the pressure-overloaded LVmyocardium to-
wards pro-angiogenic mediators and the myocardium of transplanted
mice showed an increased density of endothelial (CD31+) cells. In con-
trast, GFP+ cardiomyocytes were only identiﬁed in a small minority of
the animals despite very meticulous examination. Transplanted cells
transdifferentiated partly into smoothmuscle cells and CD31+ endothe-
lial cells and pressure overload further increased their percentage. The
histological characterization of endothelial-transdifferentiating cells
can be difﬁcult because non-endothelial GFP+ cells lay in the vicinity
of endothelial cells. To overcome this issue, we used Tie-2-GFP mice as
donor animals for additional transplantation studies. In these animals,
cells are expressing GFP by the endothelial Tie-2-promoter and c-kit+
RCSC in this model only express GFP after differentiating towards endo-
thelial phenotype (Müller et al. 2009). The data therefore strongly sug-
gest that differentiation took place. Reduction of endothelial cell
number and number of capillaries during sustained pressure overload
caused by decrease in myocardial content of Hif1α leads to progression
of heart failure. (Kazakov et al. 2012; Müller et al. 2009; Müller et al.
2008; Sano et al. 2007). Hence, the increase of the numbers of CD31-
positive endothelial cells and enhanced myocardial expression of
Hif1α after transplantation of the adult stem cells represent additional
protecting effects (Gyongyosi et al. 2010; Tillmanns et al. 2008). Circu-
lating stem cells demonstrate increased intracellular expression of
Hif1α under normoxic conditions induced by ligand of c-kit stem cell
factor (Piccoli et al. 2007). Moreover, inhibition of c-kit abrogates
Hif1α-mediated angiogenic activity of hematopoietic stem cells
and cancer cells (Litz and Krystal 2006; Pedersen et al. 2008). These
ﬁndings suggest that paracrine effects and differentiation into non-
cardiomyocytes represent the primary underlying mechanisms of the
cell therapy (Beltrami et al. 2003; Ellison et al. 2013; Elnakish et al.
2013; Li et al. 2011; Ramkisoensing et al. 2014; van Berlo et al. 2014).
Cardiac ﬁbrosis is an important part of ventricular remodeling and
an independent and predictive risk factor for heart failure (Burchﬁeld
et al. 2013; Segura et al. 2014). Pathological stress elicited by pressure
Fig. 4. Effect of intravenous transplantation of c-kit+ resident cardiac stem cells on endothelial cells, Hif1α expression and expression of angiogenesis regulators in pressure-overloaded LVmyo-
cardium. Injection of c-kit+RCSC increases the number of CD31+endothelial cells (A), but not the ratio of CD31+endothelial cells to cardiomyocyte (B), n=11–24 per group. Pressure overload
increases the percentage of CD31+ GFP+ endothelial cells in the LV myocardium (C) and stimulate differentiation of c-kit+ GFP+ RCSC into endothelial cells (D), n = 11–24 per group. Hif1α
mRNA level in the LVmyocardiumwas upregulated 24 h after transplantation of c-kit+ RCSC in the TAC+cell group and 35days later only in the SHAM+buffer group (H), n=4–5 per group.
Myocardial expression of anti-angiogenic proteins was reduced 24 h and expression of pro-angiogenic proteins was increased 5 weeks after stem cell transplantation (I), n = 4 per group. In-
jection of c-kit+RCSC reduces expression of anti-angiogenicmediators IFNγ and IFNγ inducible protein (IP-) 10 in pressure-overloaded LVmyocardium24h after transplantation (J), n=4per
group. Enhanced expression of pro-angiogenic proteins (FGFb, IL-4, IL-6, leptin, and TGFβ) in pressure-overloaded LVmyocardium 5weeks after stem cell transplantation (K), n=4 per group.
Representative sections of the LVmyocardium(E) stainedwith co-immunostaining for endothelial cellmarker CD31 (red) and cardiomyocytemarkerα-sarcomeric actin (green) respectively. A
GFP+ endothelial cell-overlay (F): CD31 (red) and GFP (green). C-kit+ RCSC from Tie-2 GFP FVB/N mice migrate to the heart and transdifferentiate partly into endothelial cells as proved by
green GFP expression driven by the endothelial cell promoter Tie-2. A Tie-2-GFP+ endothelial cell-overlay (G): α-sarcomeric actin (red) and GFP (green). Nuclei are stained blue by DAPI.
Bars = 10 μm.
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Fig. 5. Intravenous transplantation of c-kit+ resident cardiac stem cells reduces oxidative stress and cardiac ﬁbrosis in TAC. Injection of c-kit+ RCSC reduces oxidative stress in
cardiomyocytes (A) and in non-cardiomyocytes (B) in TAC, n = 11–24 per group. Transplantation of c-kit+ RCSC reduces mRNA-expression of CTGF (C) and collagen Ia2 (D) 5 weeks
after TAC, n = 11–24 per group. Both injections of stem cell buffer (E) and c-kit− cardiac cells (F) lead to a similar increase in mRNA-expression of collagen Ia2 during 5 weeks TAC,
n = 3–5 per group. Injection of c-kit+ RCSC reduces cardiac ﬁbrosis (expressed as fractional area of collagen content in % of myocardial content) (G, L) and the number of ﬁbronectin+
(I, M) and DDR2+ ﬁbroblasts per mm2 (J, N) n = 11–24 per group. Fractional area of collagen content is similarly increased after injection of stem cell buffer and c-kit− cardiac cells
5 weeks post-TAC (H, L), n = 3–5 per group. Representative sections of the LV myocardium (K) stained with co-immunostaining for marker of oxidative stress 8-hydroxy-guanosine
(red) and cardiomyocyte marker α-sarcomeric actin (green) respectively. Representative sections of the LV myocardium stained with picrosirius red (L), co-immunostaining for α-
sarcomeric actin (red) and the ﬁbroblast marker intracellular ﬁbronectin (green) (M), and co-immunostaining for α-sarcomeric actin (green) and the ﬁbroblast marker DDR2 (red)
(N). Nuclei are stained blue by DAPI. Bars = 30 μm.
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Fig. 6. Intravenous transplantation of c-kit+ resident cardiac stem cells ameliorates cell turnover and mRNA-expression of BNP and ANP in pressure-overloaded LV myocardium.
Transplantation of c-kit+ RCSC reduces the percentage of apoptotic cardiomyocytes (A) and non-cardiomyocytes (B), n = 11–24 per group. (C) and (D) show the same section of the
LV myocardium from a TAC + buffer mouse. (C) shows light microscopic staining for apoptosis (brown). (D) shows ﬂuorescence microscopy for the myocyte marker α-sarcomeric
actin (green). Apoptotic nuclei are marked by arrowheads. Nuclei are stained blue by DAPI. Transplantation of c-kit+ RCSC signiﬁcantly increases the percentage of Ki67+ cycling
cardiomyocytes in the SHAM+ cell group (E), the percentage of Ki67+ non-cardiomyocytes in the experimental groups (F) and the percentage of cycling Ki67-positive nestin-positive
GFP-negative non-cardiomyocytes in TAC + cell group (G), n = 11–24 per group. (H), (I), (J), (K) and (L) show examples of LV sections from TAC mice co-immunostained for the
proliferation marker Ki67 (red) and the following cell speciﬁc markers (in green): the myocyte marker α-sarcomeric actin (H) and (I), the endothelial cell marker podocalyxin (J), GFP
(K) and nestin (L). Cycling cardiomyocyte (H), non-cardiomyocyte (I) endothelial cell (J), GFP+ cell (K) and nestin+ cell (L) nuclei are marked by arrowheads. Arrow marks cycling a
Ki67+ GFP− non-cardiomyocyte (K). Nuclei are stained blue by DAPI. Bars = 10 μm. mRNA-expression of BNP (M) and ANP (N) in the LV myocardium and BNP protein level in the
peripheral blood (O), n = 11–24 per group.
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710 A. Kazakov et al. / Stem Cell Research 15 (2015) 700–711overload induces ﬁbroblast proliferation, migration of ﬁbrocytes to the
heart increasing production of extracellular matrix proteins such as
collagen I, collagen III and ﬁbronectin (Kazakov et al. 2013; Kazakov
et al. 2012; Müller et al. 2009; Müller et al. 2008). In our study trans-
plantation of cardiac stem cells decreased the number of ﬁbronectin-
positive ﬁbroblasts in LV and the production of the main component
of extracellular matrix, collagen I. Furthermore, cardiac ﬁbroblasts
respond to pressure overload by increase in production of speciﬁc cyto-
kines and growth factors (Segura et al. 2014). Connective tissue growth
factor plays a pivotal role in development of cardiac ﬁbrosis and hyper-
trophy (Daniels et al. 2009; Szabo et al. 2014; Yoon et al. 2010). Our
ﬁndings are consistent with previous investigations demonstrating
reduction of cardiac ﬁbrosis and cardiomyocyte hypertrophy after
diminishing CTGF-level in pressure-overloaded LV myocardium
(Szabo et al. 2014; Yoon et al. 2010). Increased oxidative stress during
pressure overload has been shown to elevate ﬁbroblast numbers and
the production of extracellular matrix in the left ventricular myocardi-
um (Segura et al. 2014). Immunostaining for oxidative stress marker
8-hydroxy-guanosine revealed signiﬁcant amelioration of oxidative
stress both in cardiomyocytes and in non-cardiomyocytes after stem
cell transplantation. Transplantation of c-kit+ RCSC but not of c-kit−
cardiac cells reduces cardiac ﬁbrosis in pressure-overloaded myocardi-
um demonstrating speciﬁcity of ﬁbrosis reduction after c-kit+ stem
cell transplantation. Therefore, intravenous transplantation of c-kit+
RCSC reduces cardiac ﬁbrosis acting on several of themain pathogenetic
mechanisms of ﬁbrogenesis.
Progression of maladaptive LV remodeling, increasedwall stress and
transition to heart failure are associated with an enhanced cardiac pro-
duction of natriuretic peptides (Hohl et al. 2013; van Veldhuisen et al.
2013). TAC led to a marked ﬁve- to twenty-fold increase of myocardial
BNP and ANP expression. The observed decrease of myocardial ANP
and BNP expression and of serum BNP conﬁrms a functional effect of
the cell therapy in addition to the reduction of cardiac ﬁbrosis.
The ﬁndings are in agreement with previous investigations demon-
strating participation of c-kit+ RCSC in myocardial adaptation to physi-
ological and pathological stimuli (Beltrami et al. 2003; Ellison et al.
2013; Li et al. 2011; van Berlo et al. 2014). Transplanted c-kit+ RCSC im-
proved parameters of LV performance in different experimentalmodels
(Beltrami et al. 2003; Ellison et al. 2013; Li et al. 2011). Recently, Ellison
et al. (Ellison et al. 2013) and vanBerlo et al. (vanBerlo et al. 2014) dem-
onstrated active differentiation of c-kit+ RCSC into cardiomyocytes,
smooth muscle cells, endothelial cells and cardiac ﬁbroblasts under
physiologic conditions, in a model of isoproterenol-induced severe
myocardial damage with preserved coronary circulation (Ellison et al.
2013) and in a model of myocardial infarction (van Berlo et al. 2014).
Stem cell factor/c-kit signaling mediates the migration of c-kit+ RCSC
to the damaged heart (Kuang et al. 2008). Both our study and the
study of Ellison et al. (Ellison et al. 2013) show a tropism of the intrave-
nously injected c-kit+ RCSC expressing CXCR4 to the myocardium and
their engrafting in extracardiac tissues. In our study pressure overload
during 3 h increased recruitment of injected cells to the LVmyocardium
by two-fold. However, the contribution of c-kit+ RCSC to the differenti-
ation into cardiomyocytes in the isoproterenol-induced damage model
was more pronounced compared to myocardial infarction (Ellison
et al. 2013; van Berlo et al. 2014). Despite careful examination, GFP+
cardiomyocytes were only found in ~10% of the TAC + cell mice in
our study. The discrepancy may be explained by different experimental
conditions and different participation of c-kit+ RCSC in various experi-
mental models. Furthermore, the decrease of cardiomyocyte loss after
stem cell transplantation can diminish cardiomyogenesis and can be
caused by paracrine effects of c-kit+ RCSC (Kawaguchi et al. 2010). Trans-
plantation of c-kit+ RCSC increased the percentage of GFP-negative
nestin-positive cardiomyocytes and percentage of cycling Ki67-positive
nestin-positiveGFP-negativenon-cardiomyocytes 5weekspost-TAC sug-
gesting proliferation and cardiomyogenic transdifferentiation of endoge-
nous cardiac stem cells (Calderone 2012; Hatzistergos et al. 2010).The new-formed small cardiomyocyte from endogenous resident cardi-
ac stem cells might contribute to increased cardiomyocyte density and
reduced cardiomyocyte cross-sectional area.
Our study has limitations: we did not study effects of other types of
resident cardiac stem cells (Dey et al. 2013), different cell culture condi-
tions (Yang et al. 2013), and the effect of different doses of transplanted
stem cells (Richardson et al. 2013) on LV remodeling in TAC. The data
support a role of HIF-1 alpha as a mediator of the positive effects after
c-kit + stem cell transplantation. However, further studies are needed
to further proof and characterize this concept. Although GFP+
cardiomyocytes were mononucleated, we cannot exclude the role of
cell fusion in their origin. However, our data set the stage for future
studies to address these issues.
In conclusion, the data show an ameliorative effect of the intrave-
nously transplanted c-kit positive resident cardiac stem cells on left
ventricular ﬁbrosis independently of the changes in afterload induced
by aortic ligation. Transplantation of ex-vivo expanded c-kit+ RCSC
reduces cardiac ﬁbrosis and stimulates expression of pro-angiogenic
proteins and endothelial density in pressure-overloaded LV myocardi-
um. Importantly, apoptosis andmarkers of oxidative stress are reduced.
These ﬁndings may provide new perspectives for the understanding of
the importance of adult c-kit+ cells for cardiac remodeling and heart
failure.
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